Ibrance Approved to Treat Advanced Breast Cancer
New Drugs , News / October 4, 2016

The FDA today granted accelerated approval to Ibrance (palbociclib) to treat metastatic breast cancer. Breast cancer in women is the second most common type of cancer; it forms in the breast tissue and in advanced cases, spreads to the surrounding...

Afinitor Approved for Advanced Breast Cancer
New Drugs , News / October 1, 2016

The FDA has approved Afinitor (everolimus) for use in combination with Aromasin (exmestane) for the treatment of certain postmenopausal women with advanced hormone-receptor positive, HER2-negative breast cancer. This drug combination is intended f...

Skip to toolbar